Repression of cardiac hypertrophy by KLF15: Underlying mechanisms and therapeutic implications

PLoS ONE

Volumn 7, Issue 5, 2012, Pages

  Leenders, Joost J ^a   Wijnen, Wino J ^a   van der Made, Ingeborg ^a   Hiller, Monika ^a   Swinnen, Melissa ^b   Vandendriessche, Thierry ^b,c   Chuah, Marinee ^b,c   Pinto, Yigal M ^a   Creemers, Esther E ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b UNIVERSITY OF LEUVEN   (Belgium)

^c FREE UNIVERSITY OF BRUSSELS   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN II; KRUPPEL LIKE FACTOR; KRUPPEL LIKE FACTOR 15; MYOCARDIN RELATED TRANSCRIPTION FACTOR A; MYOCARDIN RELATED TRANSCRIPTION FACTOR B; PARVOVIRUS VECTOR; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; DNA BINDING PROTEIN; KLF15 PROTEIN, MOUSE; MKL1 PROTEIN, HUMAN; MUTANT PROTEIN; MYOCARDIN; MYOCARDIN RELATED TRANSCRIPTION FACTOR B, MOUSE; MYOCARDIN-RELATED TRANSCRIPTION FACTOR B, MOUSE; NUCLEAR PROTEIN; ONCOPROTEIN; TRANSACTIVATOR PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; GENE OVEREXPRESSION; GENE REPRESSION; HEART VENTRICLE HYPERTROPHY; MALE; MOUSE; NONHUMAN; NUCLEAR LOCALIZATION SIGNAL; PROTEIN PROTEIN INTERACTION; VIRAL GENE DELIVERY SYSTEM; ZINC FINGER MOTIF; ANIMAL; BINDING SITE; CARDIOMEGALY; CELL DIFFERENTIATION; CELL STRAIN COS1; DISEASE MODEL; DRUG EFFECT; GENE EXPRESSION REGULATION; GENE THERAPY; GENETICS; HUMAN; METABOLISM; PROMOTER REGION;

ADENO-ASSOCIATED VIRUS;

ANGIOTENSIN II; ANIMALS; BINDING SITES; CARDIOMEGALY; CELL DIFFERENTIATION; COS CELLS; DISEASE MODELS, ANIMAL; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION; GENE THERAPY; HUMANS; MICE; MUTANT PROTEINS; NUCLEAR PROTEINS; ONCOGENE PROTEINS, FUSION; PROMOTER REGIONS, GENETIC; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS;

EID: 84860645831     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0036754     Document Type: Article

References (44)

1. Creemers EE, Wilde AA, Pinto YM, (2011) Heart failure: advances through genomics. Nat Rev Genet 12: 357-362.
2. Heineke J, Molkentin JD, (2006) Regulation of cardiac hypertrophy by intracellular signalling pathways. Nat Rev Mol Cell Biol 7: 589-600.
3. Xing W, Zhang TC, Cao D, Wang Z, Antos CL, et al. (2006) Myocardin induces cardiomyocyte hypertrophy. Circ Res 98: 1089-1097.
4. Leenders JJ, Pinto YM, Creemers EE, (2011) Tapping the brake on cardiac growth-endogenous repressors of hypertrophic signaling. J Mol Cell Cardiol 51: 156-167.
5. Fisch S, Gray S, Heymans S, Haldar SM, Wang B, et al. (2007) Kruppel-like factor 15 is a regulator of cardiomyocyte hypertrophy. Proc Natl Acad Sci U S A 104: 7074-7079.
6. Haldar SM, Lu Y, Jeyaraj D, Kawanami D, Cui Y, et al. (2010) Klf15 deficiency is a molecular link between heart failure and aortic aneurysm formation. Sci Transl Med 2: 26ra26.
7. Leenders JJ, Wijnen WJ, Hiller M, van der Made I, Lentink V, et al. (2010) Regulation of cardiac gene expression by KLF15, a repressor of myocardin activity. J Biol Chem 285: 27449-27456.
8. Gray S, Feinberg MW, Hull S, Kuo CT, Watanabe M, et al. (2002) The Kruppel-like factor KLF15 regulates the insulin-sensitive glucose transporter GLUT4. J Biol Chem 277: 34322-34328.
9. Kuwahara K, Kinoshita H, Kuwabara Y, Nakagawa Y, Usami S, et al. (2010) Myocardin-related transcription factor A is a common mediator of mechanical stress- and neurohumoral stimulation-induced cardiac hypertrophic signaling leading to activation of brain natriuretic peptide gene expression. Mol Cell Biol 30: 4134-4148.
10. Cao D, Wang Z, Zhang CL, Oh J, Xing W, et al. (2005) Modulation of smooth muscle gene expression by association of histone acetyltransferases and deacetylases with myocardin. Mol Cell Biol 25: 364-376.
11. Otteson DC, Lai H, Liu Y, Zack DJ, (2005) Zinc-finger domains of the transcriptional repressor KLF15 bind multiple sites in rhodopsin and IRBP promoters including the CRS-1 and G-rich repressor elements. BMC Mol Biol 6: 15.
12. Otteson DC, Liu Y, Lai H, Wang C, Gray S, et al. (2004) Kruppel-like factor 15, a zinc-finger transcriptional regulator, represses the rhodopsin and interphotoreceptor retinoid-binding protein promoters. Invest Ophthalmol Vis Sci 45: 2522-2530.
13. McConnell BB, Yang VW, (2010) Mammalian kruppel-like factors in health and diseases. Physiol Rev 90: 1337-1381.
14. Vandendriessche T, Thorrez L, Acosta-Sanchez A, Petrus I, Wang L, et al. (2007) Efficacy and safety of adeno-associated viral vectors based on serotype 8 and 9 vs. lentiviral vectors for hemophilia B gene therapy. J Thromb Haemost 5: 16-24.
15. Swinnen M, Vanhoutte D, Van Almen GC, Hamdani N, Schellings MW, et al. (2009) Absence of thrombospondin-2 causes age-related dilated cardiomyopathy. Circulation 120: 1585-1597.
16. Schroen B, Leenders JJ, van Erk A, Bertrand AT, van Loon M, et al. (2007) Lysosomal integral membrane protein 2 is a novel component of the cardiac intercalated disc and vital for load-induced cardiac myocyte hypertrophy. J Exp Med 204: 1227-1235.
17. Seibel NM, Eljouni J, Nalaskowski MM, Hampe W, (2007) Nuclear localization of enhanced green fluorescent protein homomultimers. Anal Biochem 368: 95-99.
18. Parmacek MS, (2007) Myocardin-related transcription factors: critical coactivators regulating cardiovascular development and adaptation. Circ Res 100: 633-644.
19. Wang DZ, Li S, Hockemeyer D, Sutherland L, Wang Z, et al. (2002) Potentiation of serum response factor activity by a family of myocardin-related transcription factors. Proc Natl Acad Sci U S A 99: 14855-14860.
20. Himeda CL, Ranish JA, Pearson RC, Crossley M, Hauschka SD, (2010) KLF3 regulates muscle-specific gene expression and synergizes with serum response factor on KLF binding sites. Mol Cell Biol 30: 3430-3443.
21. van Vliet J, Crofts LA, Quinlan KG, Czolij R, Perkins AC, et al. (2006) Human KLF17 is a new member of the Sp/KLF family of transcription factors. Genomics 87: 474-482.
22. van Vliet J, Turner J, Crossley M, (2000) Human Kruppel-like factor 8: a CACCC-box binding protein that associates with CtBP and represses transcription. Nucleic Acids Res 28: 1955-1962.
23. Wu J, Srinivasan SV, Neumann JC, Lingrel JB, (2005) The KLF2 transcription factor does not affect the formation of preadipocytes but inhibits their differentiation into adipocytes. Biochemistry 44: 11098-11105.
24. Ma H, Sumbilla CM, Farrance IK, Klein MG, Inesi G, (2004) Cell-specific expression of SERCA, the exogenous Ca2+ transport ATPase, in cardiac myocytes. Am J Physiol Cell Physiol 286: C556-564.
25. Mar JH, Antin PB, Cooper TA, Ordahl CP, (1988) Analysis of the upstream regions governing expression of the chicken cardiac troponin T gene in embryonic cardiac and skeletal muscle cells. J Cell Biol 107: 573-585.
26. Wang B, Haldar SM, Lu Y, Ibrahim OA, Fisch S, et al. (2008) The Kruppel-like factor KLF15 inhibits connective tissue growth factor (CTGF) expression in cardiac fibroblasts. J Mol Cell Cardiol 45: 193-197.
27. Creemers EE, Sutherland LB, Oh J, Barbosa AC, Olson EN, (2006) Coactivation of MEF2 by the SAP domain proteins myocardin and MASTR. Mol Cell 23: 83-96.
28. Wang D, Chang PS, Wang Z, Sutherland L, Richardson JA, et al. (2001) Activation of cardiac gene expression by myocardin, a transcriptional cofactor for serum response factor. Cell 105: 851-862.
29. Parlakian A, Tuil D, Hamard G, Tavernier G, Hentzen D, et al. (2004) Targeted inactivation of serum response factor in the developing heart results in myocardial defects and embryonic lethality. Mol Cell Biol 24: 5281-5289.
30. Small EM, Thatcher JE, Sutherland LB, Kinoshita H, Gerard RD, et al. (2010) Myocardin-related transcription factor-a controls myofibroblast activation and fibrosis in response to myocardial infarction. Circ Res 107: 294-304.
31. Medjkane S, Perez-Sanchez C, Gaggioli C, Sahai E, Treisman R, (2009) Myocardin-related transcription factors and SRF are required for cytoskeletal dynamics and experimental metastasis. Nat Cell Biol 11: 257-268.
32. Lagna G, Ku MM, Nguyen PH, Neuman NA, Davis BN, et al. (2007) Control of phenotypic plasticity of smooth muscle cells by bone morphogenetic protein signaling through the myocardin-related transcription factors. J Biol Chem 282: 37244-37255.
33. Li S, Czubryt MP, McAnally J, Bassel-Duby R, Richardson JA, et al. (2005) Requirement for serum response factor for skeletal muscle growth and maturation revealed by tissue-specific gene deletion in mice. Proc Natl Acad Sci U S A 102: 1082-1087.
34. Uchida S, Tanaka Y, Ito H, Saitoh-Ohara F, Inazawa J, et al. (2000) Transcriptional regulation of the CLC-K1 promoter by myc-associated zinc finger protein and kidney-enriched Kruppel-like factor, a novel zinc finger repressor. Mol Cell Biol 20: 7319-7331.
35. Rodriguez E, Martignetti JA, (2009) The Kruppel traffic report: cooperative signals direct KLF8 nuclear transport. Cell Res 19: 1041-1043.
36. Prasad KM, Xu Y, Yang Z, Acton ST, French BA, (2011) Robust cardiomyocyte-specific gene expression following systemic injection of AAV: in vivo gene delivery follows a Poisson distribution. Gene Ther 18: 43-52.
37. Wu Z, Asokan A, Samulski RJ, (2006) Adeno-associated virus serotypes: vector toolkit for human gene therapy. Mol Ther 14: 316-327.
38. Brown KE, (2010) The expanding range of parvoviruses which infect humans. Rev Med Virol 20: 231-244.
39. Vandenberghe LH, Wilson JM, Gao G, (2009) Tailoring the AAV vector capsid for gene therapy. Gene Ther 16: 311-319.
40. Pacak CA, Mah CS, Thattaliyath BD, Conlon TJ, Lewis MA, et al. (2006) Recombinant adeno-associated virus serotype 9 leads to preferential cardiac transduction in vivo. Circ Res 99: e3-9.
41. Inagaki K, Fuess S, Storm TA, Gibson GA, McTiernan CF, et al. (2006) Robust systemic transduction with AAV9 vectors in mice: efficient global cardiac gene transfer superior to that of AAV8. Mol Ther 14: 45-53.
42. Jaski BE, Jessup ML, Mancini DM, Cappola TP, Pauly DF, et al. (2009) Calcium upregulation by percutaneous administration of gene therapy in cardiac disease (CUPID Trial), a first-in-human phase 1/2 clinical trial. J Card Fail 15: 171-181.
43. Gao G, Vandenberghe LH, Alvira MR, Lu Y, Calcedo R, et al. (2004) Clades of Adeno-associated viruses are widely disseminated in human tissues. J Virol 78: 6381-6388.
44. Creemers EE, Pinto YM, (2011) Molecular mechanisms that control interstitial fibrosis in the pressure-overloaded heart. Cardiovasc Res 89: 265-272.